Last viewed:
PHAT
Prices are updated after-hours
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
(0.0% 1d)
(7.5% 1m)
(-5.2% 1y)
(0.0% 2d)
(0.0% 3d)
(-2.2% 7d)
(-30.5%
volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 525,546,427
http://www.phathompharma.com
Sec
Filling
|
Patents
| 25 employees
Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. It focuses on its vonoprazan product, an oral small molecule potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
gastrointestinal
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03
(Crawled : 12:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 0.0%
| O: -0.31%
H: 2.35%
C: 0.92%
conference
pharmaceuticals
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
Published: 2024-03-26
(Crawled : 12:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| -6.22%
| O: 2.3%
H: 6.7%
C: -1.78%
pharmaceuticals
SIGA Names Larry Miller General Counsel
Published: 2024-03-25
(Crawled : 12:00)
- globenewswire.com
SIGA
|
$8.325
1.15%
1.14%
620K
|
Health Technology
| -6.05%
| O: -7.42%
H: 5.73%
C: 2.96%
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| -11.07%
| O: 2.09%
H: 0.98%
C: -7.11%
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 0.72%
| O: 7.81%
H: 0.67%
C: -13.35%
business
year
update
pharmaceuticals
financial
results
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
Published: 2024-02-29
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| -9.09%
| O: 0.83%
H: 2.67%
C: -1.56%
report
business
year
update
pharmaceuticals
financial
results
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Published: 2024-02-13
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 52.65%
| O: -0.47%
H: 0.0%
C: -2.82%
voquezna
scripts
express
pharmaceuticals
commercial
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-01-31
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 43.48%
| O: 4.1%
H: 1.34%
C: -5.77%
conference
pharmaceuticals
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
Published: 2023-12-14
(Crawled : 13:00)
- globenewswire.com
HTGC
F
|
$18.46
1.15%
0.38%
660K
|
Finance
| 16.26%
| O: 0.9%
H: 2.57%
C: 1.08%
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 18.5%
| O: 0.36%
H: 12.29%
C: 7.59%
security
pharmaceuticals
expansion
agreement
Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
Published: 2023-12-06
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 9.5%
| O: 0.67%
H: 0.0%
C: -5.99%
voquezna
fda
drug
treatment
pharmaceuticals
application
Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
Published: 2023-11-28
(Crawled : 13:00)
- globenewswire.com
PHAT
|
$8.98
-5.27%
-5.57%
590K
|
Health Technology
| 35.73%
| O: 0.42%
H: 3.86%
C: -1.1%
voquezna
treatment
pharmaceuticals
commercial
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001395064-24-000008
4
2024-01-25
2024-01-24
Sell
S
3703703
3755583